Search results for: 'Vitro Diagnostics Market'

10 May 2018  |  North America  |  Market Research

Global Tissue Diagnostics Market, Forecast to 2022

Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market

Infographics

×

Key Issues Addressed

Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...

This research service provides an analysis of various aspects of the molecular diagnostics market in Europe for the years 2007 - 2015. The market has been divided into four segments: infectious diseases, genetic diseases, oncology and pharmacogenomics. The market has been covered segment wise, as well as geography wise, covering seven countries and...

This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...

This research service analyses the IVD in Korea, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

Diagnostics are central to healthcare, but not accessible to all. A 2020 Lancet study states that 47% of the global population has little to no access to accurate diagnostics, emphasizing the need for equitable distribution across geographies and containing procurement costs. The COVID-19 pandemic increased demand for personal protective equipment,...

This study aims to cover the regulatory outlook and the diagnostics and drug approval process in the US, Europe, India, China, Japan and Brazil. Comparative analysis enables competitors to understand various regulatory hurdles and to position their products in pipeline better and plan for costs. Comparative analysis also enables an understanding of...

The Mobility Technology Opportunity Engine (TOE) covers innovations pertaining to EV Battery Health Diagnostics, EV Charging, Single-chip LiDAR, and Mobility Platforms. Some of the innovations profiled include Automated Battery Replacement and Health Diagnostics for Electric Vehicles, Digital Business Management Platform for Truckers, Single-chip L...

This research service examines the advancements in epifluidic diagnostics technology, identifying the growth opportunities they present for the healthcare industry. Epifluidic diagnostics is an emerging class of wearable diagnostics that enables sweat and interstitial fluid (ISF) analysis through skin-interfaced microfluidic systems. These body-wor...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...